6th Annual

MPN-MDS

Focus Meeting 2025

calendar icon

Downright Austin, A Renaissance Hotel, Austin, TX

calendar icon

April 11 - 12, 2025

Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the MPN-MDS Focus Meeting 2025, to be held at on April 11 - 12, 2025.

Centered around the theme “Updating Knowledge & Clinical Practice in 2025” this meeting provides pivotal collaboration aimed at advancing MPN-MDS research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of MPN-MDS Focus Meeting 2025:

Headshot of Chair: Rami Komrokji, MD

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL

Headshot of Chair: Prithviraj Bose, MD

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX

What do Our Chairs Think?

Chair thumbnail image

Rami Komrokji, MD

Chair thumbnail image

Prithviraj Bose, MD

Thanks to Our Supporters

Agenda & Faculty

April 11, 2025 | Day 1

08:00 AM
Registration Opens
09:00 AM
Panel Discussion
Headshot of Claire Harrison, MD

Claire Harrison, MD

Guy’s and St. Thomas’ NHS Foundation Trust, London, UK

Session I: Clonal Hematopoiesis, Classifications and Risk Assessment of MPN and MDS


Moderated by:

Headshot of Sanam Loghavi, MD

Sanam Loghavi, MD

MD Anderson Cancer Center, Houston, TX
09:20 AM
Lunch Break + Faculty and Fellow Photo
Headshot of Zhuoer Xie, MD

Zhuoer Xie, MD

Moffitt Cancer Center, Tampa, FL
10:10 AM
Panel Discussion
Headshot of Danielle Hammond, MD

Danielle Hammond, MD

MD Anderson Cancer Center, Houston, TX
10:30 AM
Q&A Discussion
Headshot of Amy DeZern, MD

Amy DeZern, MD

Johns Hopkins Medicine, Baltimore, MD
10:40 AM
Q&A Discussion
Headshot of Andrew Kuykendall, MD

Andrew Kuykendall, MD

Moffitt Cancer Center, Tampa, FL
10:50 AM
Panel Discussion
11:00 AM
Coffee Break & Networking
11:20 AM
Product Theatre Supported by GSK

Session II: Atypical and Indolent MPNs


Moderated by:

Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX
12:05 PM
Adjourn
Headshot of Daniel J. DeAngelo, MD

Daniel J. DeAngelo, MD

Dana-Farber Cancer Institute, Boston, MA
12:25 PM
Update on Epidemiology and Outcomes of MPNs
Headshot of Pankit Vachhani, MD

Pankit Vachhani, MD

The University of Alabama, Alabama
12:40 PM
Moving Towards Disease Modification in Polycythemia Vera
Headshot of Raajit K. Rampal, MD

Raajit K. Rampal, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
12:55 PM
Hepcidin Mimetics and Inducers in Polycythemia Vera
Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX
01:10 PM
Updates in Essential Thrombocythemia: Where is the Field Headed?
Headshot of Abdulraheem Yacoub, MD

Abdulraheem Yacoub, MD

University of Kansas Medical Center, Kansas City, KS
01:25 PM
Panel Discussion
01:45 PM
Lunch Break + Faculty and Fellow Photo

Session III: Myelofibrosis


Moderated by:

Headshot of Prithviraj Bose, MD

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX
02:35 PM
Integration of Immune-therapy into Frontline ALL – HCVAD Experience
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
02:55 PM
Management of Anemia in MF: Current and Emerging Options
Headshot of Stephen T. Oh, MD

Stephen T. Oh, MD

Washington University, Missouri
03:10 PM
The Odyssey of JAK Inhibitors for the Treatment of MF
Headshot of Ruben Mesa, MD

Ruben Mesa, MD

MD Anderson Cancer Center, Houston, TX
03:25 PM
Novel Small Molecules and JAK Inhibitor-based Combos for MF
Headshot of Prithviraj Bose, MD

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX
03:40 PM
Coffee Break & Networking

Rising Stars in MPN


Moderated by:

Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX

Debate: Clinical Trial Endpoints & Outcomes in MF: Time for a Change or Keep Status Quo?

04:00 PM
Yes: It’s Time for New Endpoints and Outcomes in MF Clinical Trials Beyond Spleen & Symptoms EFS, PFS, OS
Headshot of Hannah Goulart, MD

Hannah Goulart, MD

MD Anderson Cancer Center, Houston, TX
04:10 PM
No: Let’s keep Spleen & Symptoms and Current Criteria for MF Response
Headshot of Sankalp Arora, MD

Sankalp Arora, MD

MD Anderson Cancer Center, Houston, TX
04:20 PM
Q&A Discussion

Debate: Frontline MF: Debating Combination Therapy vs Staying with Monotherapy

04:30 PM
Yes: Frontline Combos for MF Are The Future because Two Drugs Are Better than One
Headshot of Mahesh Swaminathan, MD

Mahesh Swaminathan, MD

MD Anderson Cancer Center, Houston, TX
04:40 PM
No: Let’s Stay with JAKi Monotherapy for Frontline MF
Headshot of Fadi Haddad, MD

Fadi Haddad, MD

MD Anderson Cancer Center, Houston, TX
04:50 PM
Q&A Discussion
05:00 PM
Erythroid Maturating Agents for Management of Anemia in MDS
Headshot of Guillermo Garcia-Manero, MD

Guillermo Garcia-Manero, MD

MD Anderson Cancer Center, Houston, TX
05:15 PM
Adjourn

April 12, 2025 | Day 2

08:00 AM
Registration Opens
09:00 AM
Keynote Speaker; TP53 Myeloid Neoplasms
Headshot of David Sallman, MD

David Sallman, MD

Moffitt Cancer Center, Tampa, FL

Session IV: MDS I


Moderated by:

Headshot of Uma Borate, MD

Uma Borate, MD

The Ohio State University, Ohio
09:30 AM
Telomerase Inhibitors for Treatment of MDS
Headshot of Amer Zeidan, MD

Amer Zeidan, MD

Yale School of Medicine, Connecticut
09:45 AM
Investigational Therapies in Lower-risk MDS
Headshot of Yazan Madanat, MD

Yazan Madanat, MD

UT Southwestern Medical Center, Dallas, Texas
10:00 AM
Investigational Therapies for Higher-risk MDS
Headshot of Uma Borate, MD

Uma Borate, MD

The Ohio State University, Ohio
10:15 AM
IDH Mutated MDS
Headshot of Rami Komrokji, MD

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL
10:30 AM
Panel Discussion
10:50 AM
Coffee Break & Networking
11:10 AM
Independent Expert discussion Supported by BMS

Session V: MDS II


Moderated by:

Headshot of Mikkael A. Sekeres, MD

Mikkael A. Sekeres, MD

University of Miami Miller School of Medicine, Miami, FL
11:55 AM
Two Decades of Clinical Trials in MDS: Lessons Learned
Headshot of Mikkael A. Sekeres, MD

Mikkael A. Sekeres, MD

University of Miami Miller School of Medicine, Miami, FL
12:10 PM
CMML Update
Headshot of Eric Padron, MD

Eric Padron, MD

Moffitt Cancer Center, Tampa, FL
12:25 PM
MDS/MPN Other than CMML Updates
Headshot of Guillermo Montalban Bravo, MD

Guillermo Montalban Bravo, MD

MD Anderson Cancer Center, Houston, TX
12:40 PM
CML Updates
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
12:55 PM
Panel Discussion
01:15 PM
Lunch Break + Faculty and Fellow Photo

Session VI: AHSCT in MDS and MPN


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
02:05 PM
Stem Cell Transplantation and Cellular Therapies for MF
Headshot of Tania Jain, MD

Tania Jain, MD

Johns Hopkins University, Baltimore, MD
02:20 PM
Do We Need Treatment Before and After AHSCT for MDS
Headshot of Alain Mina, MD

Alain Mina, MD

Northwestern Memorial Hospital, Chicago, IL
02:35 PM
Treatment of Secondary AML from MDS and MPN
Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
02:50 PM
Stem Cell Transplantation and Cellular Therapies for MDS
Headshot of Bart Scott, MD

Bart Scott, MD

Fred Hutchinson Cancer Center, Seattle, WA
03:05 PM
Panel Discussion
03:25 PM
Coffee Break & Networking

Rising Stars in MDS


Moderated by:

Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX

Debate: Stem Cell Transplant in TP53-MDS

03:45 PM
Yes: Still Offer for All Eligible Despite Limitations
Headshot of Somedeb Ball, MD

Somedeb Ball, MD

Vanderbilt University Medical Center, Nashville, Tennessee
03:55 PM
No: SCT is Not Effective for TP53 MDS
Headshot of Tamanna Haque, MD

Tamanna Haque, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
04:05 PM
Q&A Discussion

Debate: Pre-emptive Treatment of preMDS in the Future: Pros and Cons

04:15 PM
Yes: Chemoprevention, Treatment and SCT Will Be Used in All Patients Ultimately Before Development of CCUS, MDS, AML
Headshot of Kelly Chien, MD

Kelly Chien, MD

MD Anderson Cancer Center, Houston, TX
04:25 PM
No: Chemoprevention and Treatment of CHIP Will Never Be Implemented Widely or Universally
Headshot of Ashwin Kishtagari, MD

Ashwin Kishtagari, MD

Vanderbilt University Medical Center, Nashville, TX
04:35 PM
Q&A Discussion
04:45 PM
Adjourn

Aimee Williams

Project Manager

How long has Aimee Williams been in the business?

Aimee Williams has been with MD Education since 2022

About Aimee Williams

I joined MD Education in 2022 as a Project Manager, leveraging my background in events management and passion for high-quality results. After earning a degree in Events Management, I gained hands-on experience managing projects while living in Nashville, TN. Driven and detail-oriented, I thrive in fast-paced environments, ensuring projects meet the highest standards. An avid traveler, I bring creativity and open-mindedness to problem-solving and client relationships.